News from dipexium pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 08, 2014, 08:00 ET

Dipexium Pharmaceuticals Presents Updated Locilex® Microbiology Data at 54th ICAAC Conference

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Sep 02, 2014, 08:00 ET

Dipexium Pharmaceuticals Announces Presentation at Rodman & Renshaw 16th Annual Global Investment Conference

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Aug 12, 2014, 16:01 ET

Dipexium Pharmaceuticals Reports Second Quarter 2014 Financial and Operational Results

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of...

Jul 21, 2014, 08:00 ET

Dipexium Pharmaceuticals Initiates Second of Two Pivotal Phase 3 Clinical Trials of Locilex® in Patients with Mild Infections of Diabetic Foot Ulcers

 Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) today announced it has initiated patient enrollment in the second of two pivotal Phase 3...

Jul 17, 2014, 08:01 ET

Dipexium Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Locilex® in Patients with Mild Infections of Diabetic Foot Ulcers

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) today announced it has initiated patient enrollment in the first of two pivotal Phase 3 clinical...

Jul 17, 2014, 08:00 ET

Dipexium Pharmaceuticals Announces Successful Completion of Phase 1 Skin Irritation Trial of Locilex®

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) today announced successful completion and initial results of DPX-110,  a Phase 1 skin irritation...

Jun 23, 2014, 10:38 ET

Dipexium Pharmaceuticals, Inc. on Preliminary List of Additions to Russell Microcap® Index

 Dipexium Pharmaceuticals, Inc. (NasdaqCM: DPRX), today announced it was included in the preliminary list of additions to the Russell...

Jun 23, 2014, 08:00 ET

Dipexium Pharmaceuticals, Inc. on Preliminary List of Additions to Russell Microcap® Index

 Dipexium Pharmaceuticals, Inc. (NasdaqCM: DPRX), today announced it was included in the preliminary list of additions to the Russell...

Mar 18, 2014, 11:00 ET

Dipexium Pharmaceuticals Closes Initial Public Offering

 Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX), a late stage biopharmaceutical company developing Locilex™ (pexiganan acetate cream 1%), a...

Mar 13, 2014, 08:00 ET

Dipexium Pharmaceuticals Prices Initial Public Offering of Common Stock

Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX), a late stage biopharmaceutical company developing Locilex™ (pexiganan acetate cream 1%), a...

Sep 10, 2013, 08:00 ET

Dipexium Provides Locilex™ Manufacturing Update

 Dipexium Pharmaceuticals, LLC today announced modifications made to the Locilex™ (pexiganan acetate cream 1%) formulation have resulted...

Jul 09, 2013, 08:00 ET

Dipexium Pharmaceuticals Announces the Issuance of a New U.S. Patent for Locilex™

 Dipexium Pharmaceuticals, LLC today announced it received a notice of allowance from the U.S. Patent and Trademark Office for a patent...

Jan 03, 2013, 16:16 ET

Dipexium se voit accordée l'évaluation spéciale du protocole par la FDA pour l'étude clinique en phase 3 pour les infections légères des ulcères du pied diabétique par Locilex ™

 Dipexium Pharmaceuticals, LLC annonce aujourd'hui qu'elle a conclu une entente avec la Food and Drug Administration des Etats-Unis...

Jan 03, 2013, 10:14 ET

Dipexium wurde von der FDA die spezielle Protokollbewertung für die Phase-III-Zulassungsstudie mit Locilex™ bei leicht infizierten, diabetesbedingten Fußgeschwüren bewilligt

Dipexium Pharmaceuticals, LLC gab heute bekannt, man habe mit der US-Bundesbehörde zur Lebens- und Arzneimittelüberwachung („FDA")...

Jan 03, 2013, 08:00 ET

Dipexium Granted Special Protocol Assessment by the FDA for Phase 3 Registration Trial in Mildly Infected Diabetic Foot Ulcers With Locilex™

 Dipexium Pharmaceuticals, LLC today announced that it has reached an agreement with the U.S. Food and Drug Administration ("FDA") on a Special...

Apr 05, 2011, 13:29 ET

Dipexium Pharmaceuticals fait le point sur le développement de Locilex(TM) et fixe ses objectifs pour 2011

Dipexium Pharmaceuticals a fait le point aujourd'hui sur ses activités de développement et a annoncé les étapes qu'elle...

Apr 05, 2011, 00:53 ET

Dipexium Pharmaceuticals informiert über neuesten Stand der Entwicklung von Locilex(TM) und gibt Meilensteine für 2011 bekannt

Dipexium Pharmaceuticals gab heute aktuelle Informationen zu seinen Entwicklungsanstrengungen und zu den Meilensteinen bekannt, die im Laufe...

Apr 04, 2011, 10:52 ET

Dipexium Pharmaceuticals Updates Locilex™ Development Activities and Announces 2011 Milestones

Dipexium Pharmaceuticals today provided an update of its development activities and announced its milestones to be achieved during 2011. Management...

Oct 19, 2010, 18:38 ET

Dipexium Pharmaceuticals Raises $1.4 Million in Private Offering

Dipexium Pharmaceuticals today announced that it has raised aggregate gross proceeds of $1.4 million in a private offering of its Class A Member...